When You Need Mealtime Insulin but Can't Get Afrezza

Maybe your pharmacy is out of stock. Maybe your insurance won't cover it. Maybe the cost is just too high right now. Whatever the reason, if you can't fill your Afrezza 180 Titration Pack- 60, 60, 60 prescription, you still need mealtime insulin — and there are solid alternatives.

This guide covers what Afrezza does, how it works, and the best alternatives to discuss with your doctor.

What Is Afrezza?

Afrezza is a rapid-acting inhaled insulin approved by the FDA for adults with type 1 and type 2 diabetes. Made by MannKind Corporation, it's the only insulin you breathe in rather than inject. You use it at the beginning of each meal to manage blood sugar spikes.

The 180 Titration Pack includes single-use cartridges in different strengths (4, 8, and 12 units) so you and your doctor can find the right dose for each meal.

How Does Afrezza Work?

When you inhale Afrezza, the insulin powder is delivered deep into your lungs, where it's quickly absorbed into your bloodstream. It starts working within about 12 to 15 minutes — faster than most injectable rapid-acting insulins — and peaks at around 60 minutes. This rapid onset mimics the way a healthy pancreas releases insulin in response to food.

Because it works through the lungs, Afrezza is not suitable for people with chronic lung disease like asthma or COPD. A lung function test (spirometry) is required before you can start using it.

Alternatives to Afrezza

If you can't get Afrezza, the most common alternatives are injectable rapid-acting insulins. These work the same way — lowering blood sugar at mealtimes — but are given by injection (usually with a pen or syringe) rather than inhaled.

1. Humalog (Insulin Lispro)

Humalog is one of the most widely prescribed rapid-acting insulins. It starts working within 15 to 30 minutes and lasts about 3 to 5 hours. A generic version (insulin lispro) is available, making it significantly cheaper than Afrezza. It comes in vials, pens, and pump cartridges.

2. NovoLog (Insulin Aspart)

NovoLog is another popular rapid-acting insulin with a similar profile to Humalog. It also has a generic version (insulin aspart) available. NovoLog is widely stocked at pharmacies and covered by most insurance plans.

3. Apidra (Insulin Glulisine)

Apidra is a third rapid-acting injectable option. It has a slightly faster onset than Humalog and NovoLog in some patients. It's less commonly prescribed but remains a solid alternative, especially if you've had issues with the other options.

4. Fiasp (Insulin Aspart, Fast-Acting)

Fiasp is an ultra-rapid-acting insulin made by Novo Nordisk. It starts working even faster than standard rapid-acting insulins — within about 2.5 minutes — making it the closest injectable alternative to Afrezza's speed. It's available in pens and vials.

How to Choose the Right Alternative

The best alternative depends on your specific situation:

• If cost is the issue: Generic insulin lispro or insulin aspart are far cheaper than Afrezza, often $30-$100 per vial with discount cards.
• If speed matters most: Fiasp has the fastest onset among injectables.
• If you hate needles: Talk to your doctor about insulin pens (less intimidating than syringes) or insulin pumps, which reduce the number of daily injections.
• If it's a temporary gap: Any of these can bridge you until Afrezza is back in stock. Use Medfinder to check Afrezza availability in your area.

Final Thoughts

Afrezza is unique and there's no exact replacement for inhaled insulin. But the goal — controlling mealtime blood sugar — can be achieved with several well-proven injectable alternatives. Talk to your doctor about which one makes the most sense for you.

In the meantime, don't stop looking for Afrezza. Check Medfinder regularly, and read our guides on why Afrezza is hard to find and how to save money on Afrezza for more help.